Links
[1] https://www.biosimilardevelopment.com/doc/multi-stakeholder-biosimilar-crucial-milestone-increased-patient-access-biological-therapies-0001
[2] https://www.centerforbiosimilars.com/news/ema-publishes-new-educational-materials-on-biosimilars
[3] https://www.imfarmacias.es/noticia/16076/los-farmaceuticos-hospitalarios-claves-en-la-eficiencia-y-el-acceso-de-los-biosimilares#.W6C1gQIvLnQ.twitter
[4] http://isanidad.com/121972/especialistas-en-biosimilares-debaten-como-ampliar-y-mejorar-su-aplicacion-en-la-ue/
[5] https://www.immedicohospitalario.es/noticia/14805/los-farmaceuticos-hospitalarios-claves-en-la-eficiencia-y-el-acceso
[6] http://www.elglobal.net/farmacia/el-presidente-de-la-sefh-defiende-en-bruselas-la-labor-de-los-farmaceuticos-hospitalarios-en-la-eficiencia-y-el-acceso-de-los-biosimilares-AA1736211
[7] https://www.redaccionmedica.com/secciones/farmacia-hospitalaria/la-sefh-defiende-en-europa-el-papel-del-farmaceutico-ante-los-biosimilares-6250
[8] http://www.gacetamedica.com/suplementos/farmacia-hospitalaria/la-farmacia-hospitalaria-europea-avanza-en-el-acceso-a-las-terapias-biologicas-JG1778795
[9] https://www.diariofarma.com/2018/09/17/calleja-asigna-al-fh-un-papel-clave-para-gestionar-el-uso-de-biosimilares